ACCELERATING MEDICAL INNOVATION

Live / Registered — Registered and renewed (as of 16 Nov 2019)

What this means for you

Registered since 27 Jul 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Jul 2020).

Record

Serial number
77600170
Registration number
3825874
Mark type
Stylized text
Filed
24 Oct 2008
Published for opposition
14 Jul 2009
Registered
27 Jul 2010
Next maintenance due
27 Jul 2020
Attorney of record
Robert J. Kenney

Goods and services

  • Class 035 — Advertising and business services: Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
  • Class 040 — Treatment of materials: Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals
  • Class 042 — Scientific and technological services: Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics
  • Class 045 — Legal and security services: Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Owner

Prosecution history

  • 10 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 10 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 10 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 10 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Nov 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 16 Nov 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 16 Nov 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 16 Nov 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 09 Oct 2019 — TEAS SECTION 8 & 9 RECEIVED
  • 27 Jul 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 20 Jun 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 20 Jun 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 19 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
  • 19 Mar 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
  • 19 Mar 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL

View this trademark record on Marksy